Form 4: Molina Healthcare Director Daniel Cooperman Acquires Shares Under Equity Incentive Plan

Director Daniel Cooperman acquired 188 shares of Molina Healthcare common stock on July 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

• On July 1, 2024, Daniel Cooperman, a director of Molina Healthcare, Inc., acquired 188 shares of common stock.
• The acquisition was part of the Issuer's 2019 Equity Incentive Plan, related to Cooperman's service as a Director.
• The shares were granted at a price of $292.16 per share, reflecting the closing price of Molina Healthcare's common stock on that day.
• Following the transaction, Cooperman directly owns 5,977 shares of Molina Healthcare common stock.
• The annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it shows alignment of director interests with shareholders.

Positives

• The equity incentive plan aligns director compensation with company performance.
• Director Cooperman increased his stake in the company, showing confidence.

Industry Context

This type of equity grant is a common practice for compensating board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages, including equity grants, are common across the healthcare industry.
• Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize equity-based compensation for their board members.
• The specific amount and vesting schedules can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates